ArticleClinical pharmacokinetics2021

Drug-Drug Interaction Studies of Elagolix with Oral and Transdermal Low-Dose Hormonal Add-Back Therapy.

Ahmed Nader et al.PubMed ↗Publisher ↗

No numbers read from the abstract.